FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marina Klein

Research Profile

Disorders

Procedures

Living Beings

Geographic Areas

Canada

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Nitika Pant Pai; A Singam; R Barick; S Chhabra; Y Jafari; Marina B Klein; J Kurji; P Shivkumar
Simultaneous triple point-of-care testing for HIV, syphilis and hepatitis B virus to prevent mother-to-child transmission in India.
Darrell H S Tan; Chris Tsoukas; Sharon Walmsley; Keith Chan; Curtis Cooper; Robert S Hogg; Marina B Klein; Mona R Loutfy; Nima Machouf; Julio S G Montaner; Janet Raboud; Sean B Rourke
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy.
Julia Thorpe; Sahar Saeed; Erica E M Moodie; Marina B Klein
Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marina Klein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Nitika Pant Pai; A Singam; R Barick; S Chhabra; Y Jafari; Marina B Klein; J Kurji; P Shivkumar
Simultaneous triple point-of-care testing for HIV, syphilis and hepatitis B virus to prevent mother-to-child transmission in India.
International journal of STD & AIDS 2012;23(5):319-24.
2011: Darrell H S Tan; Chris Tsoukas; Sharon Walmsley; Keith Chan; Curtis Cooper; Robert S Hogg; Marina B Klein; Mona R Loutfy; Nima Machouf; Julio S G Montaner; Janet Raboud; Sean B Rourke
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy.
Journal of acquired immune deficiency syndromes (1999) 2011;58(1):38-46.
2011: Julia Thorpe; Sahar Saeed; Erica E M Moodie; Marina B Klein
Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection.
AIDS (London, England) 2011;25(7):967-75.
2011: Marina B Klein; Richard Lalonde; Marie-France Matte; Marc Poliquin; Annie Talbot; Rachel Therrien; Cécile Tremblay; Benoit Trottier; Irina Tsarevsky; Jean-Guy Baril; Marc-André Charron; Claude Fortin; Jean-Pierre Villeneuve
Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals.
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada 2011;22(3):88-96.
2010: Mona R Loutfy; Miguel Genebat; David Moore; Janet Raboud; Keith Chan; Tony Antoniou; David Milan; Anya Shen; Marina B Klein; Curtis Cooper; Nima Machouf; Sean B Rourke; Anita Rachlis; Chris Tsoukas; Julio S G Montaner; Sharon L Walmsley; Marek Smieja; Ahmed M Bayoumi; Edward Mills; Hogg Robert
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
Journal of acquired immune deficiency syndromes (1999) 2010;55(4):451-9.
2010: Marina B Klein; Sahar Saeed; Hong Yang; Jeff Cohen; Brian Conway; Curtis Cooper; Pierre Côté; Joseph Cox; John Gill; David Haase; Shariq Haider; Julio Montaner; Neora Pick; Anita Rachlis; Danielle Rouleau; Roger Sandre; Mark Tyndall; Sharon Walmsley
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study.
International journal of epidemiology 2010;39(5):1162-9.
2010: Bahareh Vali; R Brad Jones; Ali Sakhdari; Prameet M Sheth; Kiera Clayton; Feng-Yun Yue; Gabor Gyenes; David Wong; Marina B Klein; Sahar Saeed; Erika Benko; Colin Kovacs; Rupert Kaul; Mario A Ostrowski
HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
European journal of immunology 2010;40(9):2493-505.
2010: Martin Potter; Adefowope Odueyungbo; Hong Yang; Sahar Saeed; Marina B Klein
Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
AIDS (London, England) 2010;24(12):1857-65.
2010: Marina B Klein; Hong Yang; Lina DelBalso; Julie Carbonneau; Eric Frost; Guy Boivin
Viral pathogens including human metapneumovirus are the primary cause of febrile respiratory illness in HIV-infected adults receiving antiretroviral therapy.
The Journal of infectious diseases 2010;201(2):297-301.
2010: Janet M Raboud; Mona R Loutfy; DeSheng Su; Ahmed M Bayoumi; Marina B Klein; Curtis Cooper; Nima Machouf; Sean Rourke; Sharon Walmsley; Anita Rachlis; P Richard Harrigan; Marek Smieja; Christos Tsoukas; Julio S G Montaner; Hogg Robert
Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
BMC infectious diseases 2010;10():40.
2009: Marina Keller; Ying Lu; Richard G Lalonde; Marina B Klein
Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare.
AIDS (London, England) 2009;23(6):731-7.
2009: Nitika Pant Pai; Marina B Klein
Rapid testing at labor and delivery to prevent mother-to-child HIV transmission in developing settings: issues and challenges.
Women's health (London, England) 2009;5(1):55-62.
2008: Marina B Klein; Curtis Cooper; Marie-Josée Brouillette; Nancy Sheehan; Chawki Benkelfat; Lawrence Annable; Francine Weston; Deborah Kraus; Joel Singer
CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.
Contemporary clinical trials 2008;29(4):617-30.
2008: Nitika Pant Pai; Ritu Barick; Jacqueline P Tulsky; Poonam V Shivkumar; Deborah Cohan; Shriprakash Kalantri; Madhukar Pai; Marina B Klein; Shakuntala Chhabra
Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India.
PLoS medicine 2008;5(5):e92.
2007: Marina B Klein; Ying Lu; Lina DelBalso; Stéphanie Coté; Guy Boivin
Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(2):234-40.
2007: Huda Al-Mohri; Tanya Murphy; Ying Lu; Richard G Lalonde; Marina B Klein
Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.
Journal of acquired immune deficiency syndromes (1999) 2007;44(4):463-9.
2006: Mohamed-Rachid Boulassel; Rosa Morales; Tanya Murphy; Richard G Lalonde; Marina B Klein
Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons.
Journal of medical virology 2006;78(9):1158-63.
2006: Nancy E Mayo; James Brophy; Mark S Goldberg; Marina B Klein; Sydney Miller; Robert W Platt; Judith Ritchie
Peering at peer review revealed high degree of chance associated with funding of grant applications.
Journal of clinical epidemiology 2006;59(8):842-8.
2005: H Al-Mohri; C Cooper; Tanya Murphy; Marina B Klein
Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
HIV medicine 2005;6(6):375-8.
2004: Marina B Klein; Patrick Willemot; Tanya Murphy; Richard G Lalonde
The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection.
AIDS (London, England) 2004;18(14):1895-904.
2004: Patrick Willemot; Marina B Klein
Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.
Expert review of anti-infective therapy 2004;2(4):521-32.
2003: Marina B Klein; Richard G Lalonde; Samy Suissa
The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;33(3):365-72.
2003: Marina B Klein; Nadia Campeol; Richard G Lalonde; Bluma Brenner; Mark A Wainberg
Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus.
AIDS (London, England) 2003;17(7):1001-8.
1997: Marina B Klein; Richard G Lalonde
The continued occurrence of primary Pneumocystis carinii pneumonia despite the availability of prophylaxis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(3):522-3.